Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections

The increasing number of severe infections with multi-drug-resistant pathogens worldwide highlights the need for alternative treatment options. Given the pivotal role of phagocytes and especially alveolar macrophages in pulmonary immunity, we introduce a new, cell-based treatment strategy to target...

Descripción completa

Detalles Bibliográficos
Autores principales: Ackermann, Mania, Kempf, Henning, Hetzel, Miriam, Hesse, Christina, Hashtchin, Anna Rafiei, Brinkert, Kerstin, Schott, Juliane Wilhelmine, Haake, Kathrin, Kühnel, Mark Philipp, Glage, Silke, Figueiredo, Constanca, Jonigk, Danny, Sewald, Katherina, Schambach, Axel, Wronski, Sabine, Moritz, Thomas, Martin, Ulrich, Zweigerdt, Robert, Munder, Antje, Lachmann, Nico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269475/
https://www.ncbi.nlm.nih.gov/pubmed/30504915
http://dx.doi.org/10.1038/s41467-018-07570-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269475/
https://www.ncbi.nlm.nih.gov/pubmed/30504915
http://dx.doi.org/10.1038/s41467-018-07570-7

Ejemplares similares